HBsAg is the hallmark of HBV infection and is the first serological marker to appear in acute hepatitis B. Most patients recovering from acute hepatitis B clear HBsAg within 4-6 months after onset ...

Immunocore leads the way in T cell receptor-based bispecifics ... such reservoirs but Immunocore is initially focusing on hepatitis B virus (HBV) and HIV. The World Health Organization estimates ...

Similar approaches have also failed to produce effective vaccines or therapeutics for influenza, hepatitis B virus (HBV), and ... multiple copies of host cell receptors and attachment proteins.

A recent article in the journal Nature Communications describes the structural basis of mimicked HBV/HDV viral peptide drug interaction with its receptor NTCP. HBV, an enveloped DNA virus, causes ...

probably due to pressure from HBV. Such molecular evolution driven to escape virus infection has been reported for other virus receptors.” Koichi Watashi, Visiting Professor, Tokyo University of ...

Chronic HBV infection is characterized by an evolving interplay between viral replication and host immune responses. Both viral and host factors contribute to persistence of HBV. Highly efficient ...

A study reveals why monkeys resist HBV infection, showing that specific amino acid differences in their NTCP receptor prevent viral entry. Findings highlight evolution-driven resistance and inspire ...

Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional cure for ...

An international team of researchers led by Chinese medical experts has announced a discovery that could lead to a treatment for a liver virus that infects more than 250 million people worldwide ...